Sarepta Therapeutics Inc (SRPT)
131.88
-0.42
(-0.31%)
USD |
NASDAQ |
May 10, 16:00
131.88
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Price to Book Value: 12.97 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 09, 2024 | 13.01 |
May 08, 2024 | 13.04 |
May 07, 2024 | 13.38 |
May 06, 2024 | 13.28 |
May 03, 2024 | 13.14 |
May 02, 2024 | 12.85 |
May 01, 2024 | 12.87 |
April 30, 2024 | 12.46 |
April 29, 2024 | 12.67 |
April 26, 2024 | 12.66 |
April 25, 2024 | 12.53 |
April 24, 2024 | 12.22 |
April 23, 2024 | 11.52 |
April 22, 2024 | 11.50 |
April 19, 2024 | 11.37 |
April 18, 2024 | 11.46 |
April 17, 2024 | 11.59 |
April 16, 2024 | 11.53 |
April 15, 2024 | 11.63 |
April 12, 2024 | 12.08 |
April 11, 2024 | 12.24 |
April 10, 2024 | 12.42 |
April 09, 2024 | 12.48 |
April 08, 2024 | 12.43 |
April 05, 2024 | 12.39 |
Date | Value |
---|---|
April 04, 2024 | 12.37 |
April 03, 2024 | 12.48 |
April 02, 2024 | 12.48 |
April 01, 2024 | 12.62 |
March 31, 2024 | |
March 28, 2024 | 14.14 |
March 27, 2024 | 14.22 |
March 26, 2024 | 14.01 |
March 25, 2024 | 13.97 |
March 22, 2024 | 13.93 |
March 21, 2024 | 13.65 |
March 20, 2024 | 13.77 |
March 19, 2024 | 13.55 |
March 18, 2024 | 13.54 |
March 15, 2024 | 13.44 |
March 14, 2024 | 13.52 |
March 13, 2024 | 13.32 |
March 12, 2024 | 13.32 |
March 11, 2024 | 13.28 |
March 08, 2024 | 13.58 |
March 07, 2024 | 13.19 |
March 06, 2024 | 13.14 |
March 05, 2024 | 13.42 |
March 04, 2024 | 13.53 |
March 01, 2024 | 14.05 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.924
Minimum
Sep 26 2019
37.12
Maximum
Mar 07 2023
12.75
Average
11.75
Median
Jan 17 2020
Price to Book Value Benchmarks
PTC Therapeutics Inc | -- |
Amgen Inc | 33.13 |
Regenxbio Inc | 2.425 |
Apellis Pharmaceuticals Inc | 19.11 |
Alnylam Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
PE Ratio | 329.71 |
PS Ratio | 8.940 |
Price | 131.88 |
Earnings Yield | 0.30% |
Market Cap | 12.47B |
Normalized PE Ratio | 173.19 |